Rudraash Diagnostics And Labs Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 3 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
About Rudraash Diagnostics And Labs
Rudraash Diagnostics And Labs Private Limited (RDALPL) is a Private Limited Indian Non-Government Company incorporated in India on 25 August 2021 (Three years and five months 22 days old ). Its registered office is in Tiruchirappalli, Tamil Nadu, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Chenniappan Devi, Chenniappan Devi, and Suresh serve as directors at the Company.
Company Details
-
Location
Tiruchirappalli, Tamil Nadu, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U85110TN2021PTC145707
-
Company No.
145707
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
25 Aug 2021
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Chennai
Industry
Who are the key members and board of directors at Rudraash Diagnostics And Labs?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Chenniappan Devi
|
Director | 01-Mar-2023 | Current |
| Chenniappan Devi | Director | 01-Nov-2024 | Current |
|
Suresh
|
Director | 01-May-2024 | Current |
Financial Performance of Rudraash Diagnostics And Labs.
Rudraash Diagnostics And Labs Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Rudraash Diagnostics And Labs?
Unlock access to Rudraash Diagnostics And Labs's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Kadhir Bio Products Private LimitedChenniappan Devi is a mutual person
-
Raaonline Medinfo Private Limited
Chenniappan Devi is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Rudraash Diagnostics And Labs?
Rudraash Diagnostics And Labs has a workforce of 0 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Rudraash Diagnostics And Labs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rudraash Diagnostics And Labs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
